According to the research report, the global market for Quadrivalent Meningococcal Vaccine should grow from US$ 185 million in 2022 to US$ 245.2 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.

Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.

The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.

This report aims to provide a comprehensive study of the global market for Quadrivalent Meningococcal Vaccine. Report Highlights:

(1) Global Quadrivalent Meningococcal Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Quadrivalent Meningococcal Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Quadrivalent Meningococcal Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Quadrivalent Meningococcal Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Quadrivalent Meningococcal Vaccine segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Quadrivalent Meningococcal Vaccine, capacity, production and trends.

(7) Quadrivalent Meningococcal Vaccine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Polysaccharide Vaccine

Conjugate Vaccine

Market segment by application, can be divided into

Hospital

Clinic

Market segment by players, this report covers

Sanofi-Pasteur

Walvax

Chengdu Kanghua Biological Products Co., Ltd.

Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

Beijing Institute of Biological Products Co., Ltd.

CanSino Biological Co., Ltd.

Hualan Biological Vaccine Co., Ltd.

Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

1 Market Overview

1.1 Quadrivalent Meningococcal Vaccine Definition

1.2 Global Quadrivalent Meningococcal Vaccine Market Size and Forecast

1.2.1 By Revenue, Global Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

1.2.2 By Sales Volume, Global Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

1.2.3 Global Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029

1.3 China Quadrivalent Meningococcal Vaccine Market Size and Forecast

1.3.1 By Revenue, China Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

1.3.2 By Sales Volume, China Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

1.3.3 China Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Quadrivalent Meningococcal Vaccine Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Quadrivalent Meningococcal Vaccine Share in Global Market, 2018-2029

1.4.3 Quadrivalent Meningococcal Vaccine Market Size: China VS Global, 2018-2029

1.5 Quadrivalent Meningococcal Vaccine Market Dynamics

1.5.1 Quadrivalent Meningococcal Vaccine Market Drivers

1.5.2 Quadrivalent Meningococcal Vaccine Market Restraints

1.5.3 Quadrivalent Meningococcal Vaccine Industry Trends

1.5.4 Quadrivalent Meningococcal Vaccine Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023

2.2 Global Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023

2.3 Global Quadrivalent Meningococcal Vaccine Price by Company, 2018-2023

2.4 Global Quadrivalent Meningococcal Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Quadrivalent Meningococcal Vaccine Concentration Ratio

2.6 Global Quadrivalent Meningococcal Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Quadrivalent Meningococcal Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023

3.2 China Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023

3.3 China Quadrivalent Meningococcal Vaccine Quadrivalent Meningococcal Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Quadrivalent Meningococcal Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Quadrivalent Meningococcal Vaccine Domestic VS Export

3.6 China Market, Quadrivalent Meningococcal Vaccine Import & Export

3.6.1 China Market, Quadrivalent Meningococcal Vaccine Import & Export, 2018-2029

3.6.2 China Quadrivalent Meningococcal Vaccine Import & Export Trends

3.6.3 Main Sources of China Quadrivalent Meningococcal Vaccine Import

3.6.4 Export Destination of China Quadrivalent Meningococcal Vaccine

4 Quadrivalent Meningococcal Vaccine Production by Region

4.1 Global Quadrivalent Meningococcal Vaccine Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Quadrivalent Meningococcal Vaccine Manufacturers

4.3 Global Major Manufacturers, Quadrivalent Meningococcal Vaccine Capacity Expansion and Future Plans

4.4 Global Quadrivalent Meningococcal Vaccine Capacity by Region

4.5 Global Quadrivalent Meningococcal Vaccine Production by Region

4.5.1 Global Quadrivalent Meningococcal Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Quadrivalent Meningococcal Vaccine Production by Region, 2018-2023

4.5.3 Global Quadrivalent Meningococcal Vaccine Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Quadrivalent Meningococcal Vaccine Industry Chain

5.2 Quadrivalent Meningococcal Vaccine Upstream Analysis

5.2.1 Quadrivalent Meningococcal Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Quadrivalent Meningococcal Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Quadrivalent Meningococcal Vaccine Production Mode

5.6 Quadrivalent Meningococcal Vaccine Procurement Model

5.7 Quadrivalent Meningococcal Vaccine Industry Sales Model and Sales Channels

5.7.1 Quadrivalent Meningococcal Vaccine Sales Model

5.7.2 Quadrivalent Meningococcal Vaccine Typical Distributors

6 Sights by Type

6.1 Quadrivalent Meningococcal Vaccine Classification

6.1.1 Polysaccharide Vaccine

6.1.2 Conjugate Vaccine

6.2 By Type, Global Quadrivalent Meningococcal Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029

6.4 By Type, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029

6.5 By Type, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029

7 Sights by Application

7.1 Quadrivalent Meningococcal Vaccine Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Quadrivalent Meningococcal Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029

7.4 By Application, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029

7.5 By Application, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Quadrivalent Meningococcal Vaccine Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029

8.3 By Region, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Quadrivalent Meningococcal Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Quadrivalent Meningococcal Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Quadrivalent Meningococcal Vaccine Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Quadrivalent Meningococcal Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Quadrivalent Meningococcal Vaccine Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029

9.3 By Country, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.4.2 By Company, U.S. Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.5.2 By Company, Europe Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.5.3 By Type, Europe Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.6.2 By Company, China Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.6.3 By Type, China Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.7.2 By Company, Japan Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.7.3 By Type, Japan Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.8.2 By Company, South Korea Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.10.2 By Company, India Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.10.3 By Type, India Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Quadrivalent Meningococcal Vaccine Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Quadrivalent Meningococcal Vaccine Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Sanofi-Pasteur

10.1.1 Sanofi-Pasteur Company Information, Head Office, Market Area and Industry Position

10.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Sanofi-Pasteur Company Profile and Main Business

10.1.5 Sanofi-Pasteur Recent Developments

10.2 Walvax

10.2.1 Walvax Company Information, Head Office, Market Area and Industry Position

10.2.2 Walvax Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.2.3 Walvax Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Walvax Company Profile and Main Business

10.2.5 Walvax Recent Developments

10.3 Chengdu Kanghua Biological Products Co., Ltd.

10.3.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business

10.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments

10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.

10.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Profile and Main Business

10.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments

10.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.

10.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Profile and Main Business

10.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments

10.6 Beijing Institute of Biological Products Co., Ltd.

10.6.1 Beijing Institute of Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Beijing Institute of Biological Products Co., Ltd. Company Profile and Main Business

10.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments

10.7 CanSino Biological Co., Ltd.

10.7.1 CanSino Biological Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 CanSino Biological Co., Ltd. Company Profile and Main Business

10.7.5 CanSino Biological Co., Ltd. Recent Developments

10.8 Hualan Biological Vaccine Co., Ltd.

10.8.1 Hualan Biological Vaccine Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Hualan Biological Vaccine Co., Ltd. Company Profile and Main Business

10.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments

10.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

10.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

10.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Profile and Main Business

10.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Quadrivalent Meningococcal Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Quadrivalent Meningococcal Vaccine Market Restraints

Table 3. Quadrivalent Meningococcal Vaccine Market Trends

Table 4. Quadrivalent Meningococcal Vaccine Industry Policy

Table 5. Global Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million

Table 6. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company, 2018-2023

Table 7. Global Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share by Company, 2018-2023

Table 9. Global Quadrivalent Meningococcal Vaccine Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Quadrivalent Meningococcal Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Quadrivalent Meningococcal Vaccine Manufacturers Product Type

Table 13. China Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million

Table 14. China Quadrivalent Meningococcal Vaccine Revenue Market Share by Company, 2018-2023

Table 15. China Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Quadrivalent Meningococcal Vaccine Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Quadrivalent Meningococcal Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Quadrivalent Meningococcal Vaccine Import & Export Trends

Table 19. Main Sources of China Quadrivalent Meningococcal Vaccine Import

Table 20. Export Destination of China Quadrivalent Meningococcal Vaccine

Table 21. Global Headquarters and Manufacturing Base of Quadrivalent Meningococcal Vaccine Manufacturers

Table 22. Global Major Manufacturers, Quadrivalent Meningococcal Vaccine Capacity Expansion and Future Plans

Table 23. Global Quadrivalent Meningococcal Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Quadrivalent Meningococcal Vaccine Production by Region, 2018-2023, (K Units)

Table 25. Global Quadrivalent Meningococcal Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Quadrivalent Meningococcal Vaccine Upstream (Raw Materials)

Table 27. Global Quadrivalent Meningococcal Vaccine Typical Customers

Table 28. Quadrivalent Meningococcal Vaccine Typical Distributors

Table 29. By Type, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Quadrivalent Meningococcal Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Table 37. By Country, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Table 39. Sanofi-Pasteur Company Information, Head Office, Market Area and Industry Position

Table 40. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 41. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sanofi-Pasteur Company Profile and Main Business

Table 43. Sanofi-Pasteur Recent Developments

Table 44. Walvax Company Information, Head Office, Market Area and Industry Position

Table 45. Walvax Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 46. Walvax Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Walvax Company Profile and Main Business

Table 48. Walvax Recent Developments

Table 49. Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 50. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 51. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business

Table 53. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments

Table 54. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 55. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 56. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 58. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments

Table 59. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 60. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 61. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 63. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments

Table 64. Beijing Institute of Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 65. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 66. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Beijing Institute of Biological Products Co., Ltd. Company Profile and Main Business

Table 68. Beijing Institute of Biological Products Co., Ltd. Recent Developments

Table 69. CanSino Biological Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 70. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 71. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. CanSino Biological Co., Ltd. Company Profile and Main Business

Table 73. CanSino Biological Co., Ltd. Recent Developments

Table 74. Hualan Biological Vaccine Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 75. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 76. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Hualan Biological Vaccine Co., Ltd. Company Profile and Main Business

Table 78. Hualan Biological Vaccine Co., Ltd. Recent Developments

Table 79. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 80. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 81. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Profile and Main Business

Table 83. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments

List of Figure

Figure 1. Quadrivalent Meningococcal Vaccine Picture

Figure 2. By Revenue, Global Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Quadrivalent Meningococcal Vaccine Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Quadrivalent Meningococcal Vaccine Share of Global Market, 2018-2029

Figure 10. Global Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Quadrivalent Meningococcal Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Quadrivalent Meningococcal Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Quadrivalent Meningococcal Vaccine Domestic VS Export, 2022

Figure 16. Global Quadrivalent Meningococcal Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Quadrivalent Meningococcal Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Quadrivalent Meningococcal Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 19. Quadrivalent Meningococcal Vaccine Industry Chain

Figure 20. Quadrivalent Meningococcal Vaccine Procurement Model

Figure 21. Quadrivalent Meningococcal Vaccine Sales Model

Figure 22. Quadrivalent Meningococcal Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Polysaccharide Vaccine

Figure 24. Conjugate Vaccine

Figure 25. By Type, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 27. By Type, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. By Application, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Figure 33. By Application, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 34. By Application, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 35. By Application, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 36. By Application, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029, (US$/Unit)

Figure 37. By Region, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 38. By Region, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 39. North America Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 41. Europe Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 43. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 45. South America Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 49. By Company, U.S. Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 50. By Type, U.S. Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 51. By Application, U.S. Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 52. Europe Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, Europe Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 54. By Type, Europe Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, Europe Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 56. China Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, China Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 58. By Type, China Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, China Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 60. Japan Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, Japan Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 62. By Type, Japan Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, Japan Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 64. South Korea Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, South Korea Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 66. By Type, South Korea Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, South Korea Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 68. Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, Southeast Asia Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 70. By Type, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 72. India Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, India Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 74. By Type, India Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, India Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 76. Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, Middle East & Asia Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 78. By Type, Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 80. Research Methodology

Figure 81. Breakdown of Primary Interviews

Figure 82. Bottom-up Approaches

Figure 83. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)